Outsourcing In Clinical Trials UK & Ireland 2018
Streamline & Innovate Clinical Trials Operations Against A Backdrop of Shifting Priorities and Political Change The 5th Annual Outsourcing in…
DCGI seeks response from Glenmark on clinical trial deficiencies by May 12
Indian drug regulator found deficiencies in clinical trial protocols including an alleged falsification of patient enrollment data at Malpani Multispecialty…
Blockchain Concepts Emerge in Clinical Trials
The application of AI, blockchain technology, and machine learning in clinical trials is sparking a lot of interest in the…
Health Citizenship: A New Social Contract To Improve The Clinical Trial Process
Over a quarter of a million clinical trials are currently registered on clinicaltrials.gov. It’s no wonder that society has high…
Worldwide Clinical Trials partners with Datavant for real-world data pilot study
Worldwide Clinical Trials and Datavant have partnered to explore the reasons clinical trials in neurodegenerative diseases fail, and how big data…
NHS England moves to fast-track clinical trials
NHS England has unveiled new processes designed to fast track clinical trials undertaken across the NHS, and boost access for…
Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy Orchard’s fourth Rare Pediatric Disease Designation for autologous ex vivo gene therapy.
Orchard Therapeutics, a leading commercial stage company dedicated to transforming the lives of patients with rare diseases through innovative gene…
Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers
NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced…
Research team uncovers mechanism of action for a class of pore-forming bacterial toxins
Pore-forming toxins are common bacterial poisons. They attack organisms by introducing holes in cell membranes. A team of scientists at…
Scotland Leads the Way in Approval of First Licensed Treatment for Life-Threatening Genetic Disease Affecting Children
Routine access to Spinraza® (nusinersen) for type 1 spinal muscular atrophy granted, with discussions continuing to secure access for other…